These findings suggest that PXR plays an important role in drug interactions during combination therapy for T2DM and provide a theoretical basis for understanding the mechanisms underlying metformin-mediated pharmacokinetic effects. This evidence concerns the gene NR1I2 and type 2 diabetes mellitus.